Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01894802 · ClinicalTrials.gov registry record · NA
Cortical Recording and Stimulating Array Brain-Machine Interface
A NA study of Spinal Cord Injury and Tetraplegia, sponsored by Michael Boninger.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT01894802: Recruiting NA study of Spinal Cord Injury and Tetraplegia, sponsored by Michael Boninger.
NCT01894802 is a NA study of Spinal Cord Injury and Tetraplegia that is actively recruiting participants, run by Michael Boninger. The registered enrollment target is 30 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01894802, a NA study of Spinal Cord Injury and Tetraplegia, is actively recruiting participants, sponsored by Michael Boninger.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to demonstrate the safety and efficacy of using two CRS Arrays (microelectrodes) for long-term recording of brain motor cortex activity and microstimulation of brain sensory cortex.
Primary Outcome
This measure will be considered a success if the device is not removed for safety reasons during the 12-month post-implant evaluation.
Conditions Studied
Interventions
- DEVICE Implantation of CRS Arrays
Study Locations (2)
Illinois
- University of Chicago - Chicago
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-12-01 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT01894802 shows while recruiting
NCT01894802 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (65% lower).
The record links to 5 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Implantation of CRS Arrays is the first listed.
NCT01894802 reports a single indexed study location in Illinois, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01894802 about?
NCT01894802 is a clinical study titled "Cortical Recording and Stimulating Array Brain-Machine Interface". The purpose of this research study is to demonstrate the safety and efficacy of using two CRS Arrays (microelectrodes) for long-term recording of brain motor cortex activity and microstimulation of brain sensory cortex.
What is the current status of trial NCT01894802?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2013-12-01. Estimated completion is 2029-12.
What conditions does trial NCT01894802 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Tetraplegia, Brainstem Stroke, Brachial Plexus Injury, Above Elbow Amputation.
What interventions are being tested in trial NCT01894802?
The interventions under investigation include: Implantation of CRS Arrays (DEVICE).
Who is sponsoring clinical trial NCT01894802?
This trial is sponsored by Michael Boninger, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01894802 being conducted?
This trial has 2 study locations across Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01894802's enrollment target sits among peer trials
30 46th of 99 higher than 52 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
Exoskeleton and Spinal Cord Stimulation for SCI
RECRUITING · NA
-
VR Mindfulness Training for Veterans With SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI